Form 4 for SNWV SANUWAVE Health, Inc.
Accepted 2025-06-12 00:00:00 ET · period of report 2019-03-01 · accession 0001437749-25-020194 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-12 | 2023-08-05+ | SNWV | Stolarski Anthony Michael | Dir | C - Cnv Deriv | $15.00 | +110.0K | 155.4K | +243% | +$1.65M |
| DM | 2025-06-12 | 2024-10-18 | SNWV | Stolarski Anthony Michael | Dir | A - Grant | — | +196.4K | 317.7K | +162% | — |
| DM | 2025-06-12 | 2019-03-01+ | SNWV | Stolarski Anthony Michael | Dir | D - Sale to Iss | $0.00 | -118.3K | 1,761 | -99% | $0 |
| DM | 2025-06-12 | 2019-03-01+ | SNWV | Stolarski Anthony Michael | Dir | A - Grant | $897,789.14 | +255.5K | 533 | New | +$229.37B |
| DM | 2025-06-12 | 2023-08-05+ | SNWV | Stolarski Anthony Michael | Dir | C - Cnv Deriv | $0.00 | -95.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-05 | C | A | 103,114 | $15.00 | 148,473 | D | — | — | (F1) Pursuant to the terms of the Future Advance Convertible Promissory Note issued by SANUWAVE Health, Inc. (the "Company") on August 5, 2022, all principal and accrued interest due as of the maturity date, August 5, 2023, was automatically converted into shares of common stock at a conversion price of $15.00 per share. |
| 2 | Common | Common Stock | 2023-11-14 | C | A | 6,900 | $15.00 | 155,373 | D | — | — | (F2) Pursuant to the terms of the Future Advance Convertible Promissory Note issued by the Company on November 14, 2022, all principal and accrued interest due as of the maturity date, November 14, 2023, was automatically converted into shares of common stock at a conversion price of $15.00 per share. |
| 3 | Common | Common Stock | 2024-10-18 | A | A | 80,698 | — | 236,071 | D | — | — | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 4 | Common | Common Stock | 2024-10-18 | A | A | 76,215 | — | 312,286 | D | — | — | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 5 | Common | Common Stock | 2024-10-18 | A | A | 8,500 | — | 351,786 | D | — | — | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 6 | Common | Common Stock | 2024-10-18 | A | A | 5,100 | — | 322,786 | D | — | — | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 7 | Common | Common Stock | 2024-10-18 | A | A | 11,500 | — | 334,286 | D | — | — | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 8 | Common | Common Stock | 2024-10-18 | A | A | 9,000 | — | 343,286 | D | — | — | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 9 | Common | Common Stock | 2024-10-18 | A | A | 5,400 | — | 317,686 | D | — | — | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 10 | Derivative | Class O Warrant (right to buy) | 2019-03-01 | D | D | 533 | $0.00 | 0 | D | $41.25 · 2017-12-11 to 2019-03-17 | 533 Common Stock | (F4) On March 1, 2019, the Company extended the expiration date of the Class O Warrants to June 28, 2019. |
| 11 | Derivative | Stock Option (right to buy) | 2025-04-03 | A | A | — | $0.00 | — | D | $29.80 · — to 2030-04-03 | — Common Stock | (F10) Options were fully vested at the grant date. |
| 12 | Derivative | Class O Warrant (right to buy) | 2019-05-31 | D | D | 533 | $0.00 | 0 | D | $41.25 · 2019-03-01 to 2019-06-28 | 533 Common Stock | (F5) On May 31, 2019, the Company extended the expiration date of the Class O Warrants to September 3, 2019. |
| 13 | Derivative | Class O Warrant (right to buy) | 2019-05-31 | A | A | 533 | $0.00 | 533 | D | $41.25 · 2019-05-31 to 2019-09-03 | 533 Common Stock | (F5) On May 31, 2019, the Company extended the expiration date of the Class O Warrants to September 3, 2019. |
| 14 | Derivative | Future Advance Convertible Promissory Note | 2022-08-05 | A | A | 89,664 | $1,344,966.00 | 0 | D | $15.00 · 2022-08-05 to 2023-08-05 | 89,664 Common Stock | |
| 15 | Derivative | Future Advance Convertible Promissory Note | 2023-08-05 | C | D | 89,664 | $0.00 | 89,664 | D | $15.00 · 2022-08-05 to 2023-08-05 | 103,114 Common Stock | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 16 | Derivative | Common Stock Purchase Warrant (right to buy) | 2022-08-05 | A | A | 89,664 | — | 0 | D | $15.00 · 2022-08-05 to 2027-08-05 | 89,664 Common Stock | (F6) On August 5, 2022, in exchange for the discharge of $1,344,966 owed by the Company to the reporting person, the reporting person acquired from the Company a Future Advance Convertible Promissory Note with a principal amount of $1,344,966 and a conversion price of $15.00 per share of common stock and two warrants (one exercisable for 89,664 shares of common stock at an exercise price of $15.00 per share and the other exercisable for 89,664 shares of common stock at an exercise price of approximately $25.13 per share). |
| 17 | Derivative | Common Stock Purchase Warrant (right to buy) | 2024-10-18 | D | D | 89,664 | — | 89,664 | D | $15.00 · 2022-08-05 to 2027-08-05 | 89,664 Common Stock | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 18 | Derivative | Common Stock Purchase Warrant (right to buy) | 2022-08-05 | A | A | 6,000 | — | 0 | D | $25.13 · 2022-08-05 to 2027-08-05 | 89,664 Common Stock | (F6) On August 5, 2022, in exchange for the discharge of $1,344,966 owed by the Company to the reporting person, the reporting person acquired from the Company a Future Advance Convertible Promissory Note with a principal amount of $1,344,966 and a conversion price of $15.00 per share of common stock and two warrants (one exercisable for 89,664 shares of common stock at an exercise price of $15.00 per share and the other exercisable for 89,664 shares of common stock at an exercise price of approximately $25.13 per share). |
| 19 | Derivative | Common Stock Purchase Warrant (right to buy) | 2024-10-18 | D | D | 6,000 | — | 0 | D | $25.13 · 2022-08-05 to 2027-08-05 | 89,664 Common Stock | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 20 | Derivative | Future Advance Convertible Promissory Note | 2022-11-14 | A | A | 6,000 | $90,000.00 | 6,000 | D | $15.00 · 2022-11-14 to 2023-11-14 | 6,000 Common Stock | |
| 21 | Derivative | Future Advance Convertible Promissory Note | 2023-11-14 | C | D | 6,000 | $0.00 | 0 | D | $15.00 · 2022-11-14 to 2023-11-14 | 6,900 Common Stock | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 22 | Derivative | Common Stock Purchase Warrant (right to buy) | 2022-11-14 | A | A | 9,999 | — | 6,000 | D | $15.00 · 2022-11-14 to 2027-11-14 | 6,000 Common Stock | (F7) On November 14, 2022, in exchange for $90,000 in cash, the reporting person acquired from the Company a Future Advance Convertible Promissory Note with a principal amount of $90,000 and a conversion price of $15.00 per share of common stock and two warrants (one exercisable for 6,000 shares of common stock at an exercise price of $15.00 per share and the other exercisable for 6,000 shares of common stock at an exercise price of approximately $25.13 per share). |
| 23 | Derivative | Common Stock Purchase Warrant (right to buy) | 2024-10-18 | D | D | 9,999 | — | 0 | D | $15.00 · 2022-11-14 to 2027-11-14 | 6,000 Common Stock | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 24 | Derivative | Common Stock Purchase Warrant (right to buy) | 2022-11-14 | A | A | 9,999 | — | 0 | D | $25.13 · 2022-11-14 to 2027-11-14 | 6,000 Common Stock | (F7) On November 14, 2022, in exchange for $90,000 in cash, the reporting person acquired from the Company a Future Advance Convertible Promissory Note with a principal amount of $90,000 and a conversion price of $15.00 per share of common stock and two warrants (one exercisable for 6,000 shares of common stock at an exercise price of $15.00 per share and the other exercisable for 6,000 shares of common stock at an exercise price of approximately $25.13 per share). |
| 25 | Derivative | Common Stock Purchase Warrant (right to buy) | 2024-10-18 | D | D | 9,999 | — | 9,999 | D | $25.13 · 2022-11-14 to 2027-11-14 | 6,000 Common Stock | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 26 | Derivative | Asset-Backed Secured Promissory Note | 2023-07-21 | A | A | 41,333 | $100,000.00 | 0 | D | — · — to 2024-01-21 | 9,999 Common Stock | (F8) On July 21, 2023, in exchange for $100,000 in cash, the reporting person acquired from the Company an Asset-Backed Secured Promissory Note with a principal amount of $149,992.50. Pursuant to a letter agreement between the Company and the reporting person, dated as of July 21, 2023, the Company agreed to issue to the reporting person on January 21, 2024 a Future Advance Convertible Promissory Note with a principal amount of $149,992.50 and two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, each of which were exercisable for 9,999 shares of common stock. |
| 27 | Derivative | Asset-Backed Secured Promissory Note | 2024-01-21 | D | D | 1,559 | $0.00 | 9,999 | D | — · — to 2024-01-21 | 11,500 Common Stock | (F8) On July 21, 2023, in exchange for $100,000 in cash, the reporting person acquired from the Company an Asset-Backed Secured Promissory Note with a principal amount of $149,992.50. Pursuant to a letter agreement between the Company and the reporting person, dated as of July 21, 2023, the Company agreed to issue to the reporting person on January 21, 2024 a Future Advance Convertible Promissory Note with a principal amount of $149,992.50 and two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, each of which were exercisable for 9,999 shares of common stock. |
| 28 | Derivative | Future Advance Convertible Promissory Note | 2024-01-21 | A | A | 1,761 | $149,992.50 | 0 | D | $15.00 · 2024-01-21 to 2025-01-21 | 9,999 Common Stock | |
| 29 | Derivative | Future Advance Convertible Promissory Note | 2024-10-18 | D | D | — | $0.00 | 41,333 | D | $15.00 · 2024-01-21 to 2025-01-21 | 9,999 Common Stock | |
| 30 | Derivative | Common Stock Purchase Warrant (right to buy) | 2024-01-21 | A | A | — | — | 1,559 | D | $15.00 · 2024-01-21 to 2029-01-21 | 9,999 Common Stock | (F8) On July 21, 2023, in exchange for $100,000 in cash, the reporting person acquired from the Company an Asset-Backed Secured Promissory Note with a principal amount of $149,992.50. Pursuant to a letter agreement between the Company and the reporting person, dated as of July 21, 2023, the Company agreed to issue to the reporting person on January 21, 2024 a Future Advance Convertible Promissory Note with a principal amount of $149,992.50 and two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, each of which were exercisable for 9,999 shares of common stock. |
| 31 | Derivative | Common Stock Purchase Warrant (right to buy) | 2024-10-18 | D | D | — | — | 1,761 | D | $15.00 · 2024-01-21 to 2029-01-21 | 9,999 Common Stock | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 32 | Derivative | Common Stock Purchase Warrant (right to buy) | 2024-01-21 | A | A | — | — | — | D | $25.13 · 2024-01-21 to 2029-01-21 | 41,333 Common Stock | (F8) On July 21, 2023, in exchange for $100,000 in cash, the reporting person acquired from the Company an Asset-Backed Secured Promissory Note with a principal amount of $149,992.50. Pursuant to a letter agreement between the Company and the reporting person, dated as of July 21, 2023, the Company agreed to issue to the reporting person on January 21, 2024 a Future Advance Convertible Promissory Note with a principal amount of $149,992.50 and two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, each of which were exercisable for 9,999 shares of common stock. |
| 33 | Derivative | Common Stock Purchase Warrant (right to buy) | 2024-10-18 | D | D | — | — | — | D | $25.13 · 2024-01-21 to 2029-01-21 | 1,559 Common Stock | (F3) On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| 34 | Derivative | Stock Option (right to buy) | 2024-10-22 | A | A | — | $0.00 | — | D | $14.20 · — to 2034-10-22 | 1,761 Common Stock | (F9) Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date. |
| 35 | Derivative | Stock Option (right to buy) | 2024-12-31 | A | A | — | $0.00 | — | D | $22.76 · — to 2029-12-31 | — Common Stock | (F10) Options were fully vested at the grant date. |
| 36 | Derivative | Class O Warrant (right to buy) | 2019-03-01 | A | A | 533 | $0.00 | 533 | D | $41.25 · 2019-03-01 to 2019-06-28 | 533 Common Stock | (F4) On March 1, 2019, the Company extended the expiration date of the Class O Warrants to June 28, 2019. |